Considering the close relationship of SEMA3G with tumor immune infiltration in KIRC, we further assessed the correlation of SEMA3G expression with the levels of immune checkpoints (PD-1, PD-L1 and CTLA4). This evidence concerns the gene CD274 and neoplasm.